Inhibition of TLX expression significantly inhibited tumor growth and promoted antitumor immune responses by decreasing PD‐L1 expression, glioma‐associated macrophage numbers, and increasing cytotoxic lymphocyte infiltration. The gene discussed is CD274; the disease is glioma.